IBOV 166,376.43 ▼ 0.69% COLCAP 2,452.46 — — IPC MEX 68,713.60 ▼ 0.64% MERVAL 2,848,945 — — USD/BRL5.91▼ 0.45% USD/MXN19.08▼ 0.02% USD/CLP1,015▲ 0.73% USD/COP3,423▲ 1.96% USD/PEN3.44▼ 0.29% USD/ARS1,565▼ 0.02% USD/UYU40.61▲ 3.16% USD/PYG6,212▲ 2.34% USD/BOB11.64▲ 2.55% USD/DOP59.95▼ 0.08% USD/CRC441.73▲ 2.68% USD/GTQ7.64▲ 3.22% USD/HNL26.89▲ 3.31% USD/NIO36.62▲ 0.34% USD/VES913.46▼ 0.45% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.49▲ 2.35% USD/TTD6.70▲ 2.00% EUR/BRL6.49▲ 0.65% BRENT 90.11 ▼ 2.03% WTI 83.15 ▼ 0.07% IRON ORE 161.91 — — COPPER 5.51 ▼ 2.05% GOLD 3,550 ▼ 3.68% SILVER 41.60 ▼ 6.13% SOY 1,205 ▼ 0.23% CORN 450.25 ▲ 2.56% WHEAT 593.75 ▲ 2.68% COFFEE 275.50 ▼ 1.94% SUGAR 17.15 ▼ 4.93% ORANGE JUICE 131.95 ▲ 1.85% COTTON 79.96 ▲ 6.66% COCOA 5,169 ▲ 6.64% BEEF 227.33 ▲ 3.44% CATTLE 335.85 ▼ 0.34% LITHIUM 54.33 ▼ 2.23% PETR4 42.67 ▼ 1.16% VALE3 58.48 ▼ 0.88% ITUB4 40.07 ▼ 0.30% BBDC4 13.83 ▼ 1.78% ABEV3 16.08 ▲ 0.06% BBAS3 14.30 ▲ 1.27% B3SA3 14.28 ▼ 0.14% WEGE3 51.13 ▼ 0.49% PRIO3 60.20 ▼ 2.70% SUZB3 55.32 ▼ 0.50% RENT3 28.86 ▼ 2.00% AZZA3 14.63 ▼ 7.29% CSAN3 3.08 ▼ 1.60% RAIZ4 16.80 ▼ 9.14% PCAR3 3.23 ▲ 8.03% GMAT3 4.18 ▲ 3.21% PSSA3 43.96 ▼ 1.57% CVCB3 0.72 ▼ 7.69% POSI3 3.37 ▲ 6.31% SLCE3 17.53 ▼ 1.96% NATU3 4.48 ▼ 6.28% BRKM5 2.60 ▼ 1.14% RANI3 8.01 ▼ 0.74% IBOV 166,376.43 ▼ 0.69% COLCAP 2,452.46 — — IPC MEX 68,713.60 ▼ 0.64% MERVAL 2,848,945 — — USD/BRL 5.91 ▼ 0.45% USD/MXN 19.08 ▼ 0.01% USD/CLP 1,015 ▲ 0.73% USD/COP 3,423 ▲ 1.96% USD/PEN 3.44 ▼ 0.28% USD/ARS 1,565 ▼ 0.02% USD/UYU 40.61 ▲ 3.16% USD/PYG 6,212 ▲ 2.34% USD/BOB 11.64 ▲ 2.55% USD/DOP 59.95 ▼ 0.08% USD/CRC 441.73 ▲ 2.68% USD/GTQ 7.64 ▲ 3.22% USD/HNL 26.89 ▲ 3.31% USD/NIO 36.62 ▲ 0.34% USD/VES 913.46 ▼ 0.45% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.49 ▲ 2.53% USD/TTD 6.70 ▲ 2.00% EUR/BRL 6.49 ▲ 0.67% BRENT 90.11 ▼ 2.03% WTI 83.15 ▼ 0.07% IRON ORE 161.91 — — COPPER 5.51 ▼ 2.05% GOLD 3,550 ▼ 3.68% SILVER 41.60 ▼ 6.13% SOY 1,205 ▼ 0.23% CORN 450.25 ▲ 2.56% WHEAT 593.75 ▲ 2.68% COFFEE 275.50 ▼ 1.94% SUGAR 17.15 ▼ 4.93% ORANGE JUICE 131.95 ▲ 1.85% COTTON 79.96 ▲ 6.66% COCOA 5,169 ▲ 6.64% BEEF 227.33 ▲ 3.44% CATTLE 335.85 ▼ 0.34% LITHIUM 54.33 ▼ 2.23% PETR4 42.67 ▼ 1.16% VALE3 58.48 ▼ 0.88% ITUB4 40.07 ▼ 0.30% BBDC4 13.83 ▼ 1.78% ABEV3 16.08 ▲ 0.06% BBAS3 14.30 ▲ 1.27% B3SA3 14.28 ▼ 0.14% WEGE3 51.13 ▼ 0.49% PRIO3 60.20 ▼ 2.70% SUZB3 55.32 ▼ 0.50% RENT3 28.86 ▼ 2.00% AZZA3 14.63 ▼ 7.29% CSAN3 3.08 ▼ 1.60% RAIZ4 16.80 ▼ 9.14% PCAR3 3.23 ▲ 8.03% GMAT3 4.18 ▲ 3.21% PSSA3 43.96 ▼ 1.57% CVCB3 0.72 ▼ 7.69% POSI3 3.37 ▲ 6.31% SLCE3 17.53 ▼ 1.96% NATU3 4.48 ▼ 6.28% BRKM5 2.60 ▼ 1.14% RANI3 8.01 ▼ 0.74%
since 2009
Friday, November 20, 2026

Morocco Africa

Laprophan Share Sale Draws Near 7x Demand

Investors asked for far more Laprophan shares than were offered, and the Casablanca exchange will publish the final tally when trading begins.

By · · 4 min read
Twin Center office towers on Boulevard Zerktouni in Casablanca, Morocco, with traffic in the foreground
File photo / Photo: HombreDHojalata, CC BY-SA 3.0, via Wikimedia Commons

Markets: Morocco

Laprophan, a Moroccan drug maker backed by the investment firm Mediterrania Capital Partners, drew orders worth about MAD 15.3 billion (Moroccan dirhams, about US$1.5 billion) for its share sale in Casablanca, according to first returns from the placement syndicate reported on Wednesday 18 November 2026. The syndicate, the group of banks selling the shares to investors, says the figures are provisional.

Final results are due on Wednesday 25 November 2026, the day the shares start trading on the Casablanca Stock Exchange under the symbol LPH. The offer was capped at MAD 2.22 billion (about US$223 million), so demand came to nearly seven times the shares on sale.

Free daily brief — no card needed
Get every Africa story in one morning email
We build you a personalized brief around the topics you follow — free for 7 days. Love it? Your first month after that is US$1.

Key Facts

  • Who. Laprophan, a Moroccan drug maker backed by Mediterrania Capital Partners, an investment firm.
  • What. Provisional demand near seven times the offer, with more than 44,000 subscribers.
  • Where. Bourse de Casablanca, Morocco’s stock exchange, under the symbol LPH.
  • When. Final results and first trading on Wednesday 25 November 2026. As of 20 November 2026, 08:00 GMT.

Investors asked for far more Laprophan shares than were offered, and the Casablanca exchange will publish the final tally when trading begins.

Laprophan manufactures and sells medicines in Morocco, and its 2025 consolidated revenue was MAD 1.82 billion (about US$183 million), with net profit of MAD 109 million (about US$11 million), up 33.9%, according to its listing documents. The AMMC, Morocco’s market regulator, approved the prospectus on 28 October 2026.

The offer combines 4,105,500 new shares with 2,412,200 existing shares sold by current owners, all at MAD 341 (about US$34) each, according to the prospectus. Eligible employees pay MAD 273 (about US$27), and orders were taken from 9 to 17 November 2026.

Africa Intelligence

One email, every weekday morning. African markets, politics and business — filed from our newsroom in Rio.

Yesterday’s subject line: “Ghana's central bank cuts its rate to 11%”

Only the new shares bring money to the company, and about 90% of that capital increase is earmarked to buy all of Corporate Investment Holding, the parent of the laboratory Polymedic, according to Laprophan’s prospectus. The sale of existing shares pays the sellers instead, while Polymedic, founded in 1964, holds 138 licences to sell medicines, according to the same document.

Office and apartment towers in Casablanca Finance City, Morocco
File photo: office and apartment towers in Casablanca Finance City, the city’s financial district (Photo: AyourAchtouk, CC BY-SA 4.0, via Wikimedia Commons).
RT
Ask Rio Times
Latin American markets, currencies and companies.
Open the full Ask Rio Times →

The syndicate’s first returns put demand in the first tranche, a slice of the offer for large eligible investors placing orders of at least 8,800 shares (about US$300,000), at MAD 14.4 billion (about US$1.4 billion), nine times the shares reserved for it. The second tranche, open to the same eligible investors with no minimum order (press reports describe it as reserved for individuals), drew about MAD 800 million (about US$80 million), or 1.6 times its allocation, and more than 44,000 people subscribed in all.

The tranche figures add up to MAD 15.2 billion against the headline MAD 15.3 billion, a small gap that looks like rounding but that the syndicate has not explained. Bourse de Casablanca, the exchange operator, was due to consolidate all orders on 19 November.

Allocation matters because of how shares are shared out. Under the prospectus the first tranche is shared out pro rata, in proportion to orders, so at about nine times cover an investor would receive roughly one share in nine, while the second tranche fills small orders first, up to 100 shares each, and shares out the rest pro rata, meaning in proportion to orders.

The listing is also large by local standards. At MAD 2.22 billion it is about twice the roughly MAD 1.1 billion (about US$110 million) sought by T2S Group Holding, a medical-equipment distributor that listed on 27 July 2026, and about six times the MAD 375.4 million (about US$38 million) raised by the solar firm Jet Energy, which began trading on 16 November 2026.

Both of those earlier offers were covered more times than Laprophan’s, roughly 44 times for T2S and 31 times for Jet Energy, final results published when each listed, so the larger size here meant less excess demand per share. The comparison is only rough, because each offer had its own tranches, prices and investor mix.

The main condition on the use of the money sits with the Conseil de la Concurrence, Morocco’s competition authority. Laprophan’s prospectus says the Polymedic purchase depends on its prior approval, and no approval date has been published.

The next steps are fixed by the Bourse de Casablanca calendar. Allocations go to brokers on Monday 23 November 2026, and the final results and first trading follow on Wednesday 25 November.

Frequently Asked Questions

When does Laprophan start trading?

Trading under the symbol LPH is scheduled for Wednesday 25 November 2026, according to the Bourse de Casablanca calendar. The official final results are due the same day.

Are the demand figures final?

No, the syndicate describes them as provisional first returns. Final subscription results are expected at the first-listing ceremony on 25 November.

What will Laprophan do with the money?

About 90% of the new money is meant to buy the owner of the laboratory Polymedic. That purchase still needs approval from Morocco’s competition authority.

Sources

Published Friday 20 November 2026 · Source: AMMC prospectus (visa no. 033/2026, 28 October 2026); Bourse de Casablanca; Laprophan; first returns of the placement syndicate, 18-19 November 2026; AMMC operation note

Connected Coverage

Morocco Solar Firm Jet Energy Jumps 20% · Dislog IPO Wave: Morocco’s Consumer Giant Goes Public · Investing in Morocco as a Foreigner 2026 · Morocco Economy 2026: OCP, Al Mada, Banks and Families

The Big Picture

Africa: The New Scramble — why the world’s powers are competing for the continent

This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error

LatAm Markets: Live Signals → — real-time movers, turnover leaders and FX across Latin America.

Brazil runoff date: Sunday, October 25, poll closing times and when results start · Brazil runoff polls: Flávio 51%, Lula 49% · Kalshi and Polymarket odds

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.